Hermetica Superfood Encyclopedia
The Short Answer
Calophyllum inophyllum leaf and seed extracts contain neoflavonoids—particularly inophyllums A–E and P, calophyllolide, and calanolides A and B—alongside abundant phenolics and flavonoids that drive antioxidant, antimicrobial, and anti-inflammatory activity by scavenging reactive oxygen species and modulating ROS-related gene pathways. Leaf methanolic extracts demonstrate a total phenolic content of up to 289.12 mg GAE/g and a DPPH radical-scavenging IC₅₀ as low as 0.054 µg/mL, while antibacterial activity against Staphylococcus aureus produces zones of inhibition averaging 17.96 mm, supporting its traditional Micronesian application as a wound-healing and anti-infective agent.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordWoleai-gugu Calophyllum inophyllum benefits
Woleai-gugu — botanical close-up
Health Benefits
**Wound Healing and Antiseptic Action**
Leaf juice has been applied topically in Micronesian (FSM) tradition to treat wounds and prevent tetanus; phenolic compounds and neoflavonoids in the extract create an antimicrobial microenvironment that inhibits pathogens such as Staphylococcus aureus (zone of inhibition 17.96 mm) and Bacillus cereus (MIC <0.098 mg/mL in 11 of 15 tested extracts).
**Antioxidant Protection**
Methanolic bark extracts exhibit exceptional DPPH radical-scavenging capacity with an IC₅₀ of 0.004 mg/mL, driven by high total phenolic and flavonoid contents; leaf extracts optimized at 80% methanol/30°C/48 h yield up to 410.4 mg QE/g total flavonoid content, reflecting potent free-radical neutralization.
**Anti-Cancer Cell Proliferation Inhibition**
In vitro studies on patient-derived breast and lung cancer cell lines show that C. inophyllum extracts reduce intracellular ROS, suppressing cancer cell proliferation, migration, and invasion at 72 hours, with selective cytotoxicity against malignant cells and no cytotoxicity to normal cells observed at 24 hours.
**Anti-Inflammatory Effects**
Calophyllolide, a neoflavonoid abundant in seed resin oil, inhibits inflammatory pathways; combined with phenolics and flavonoids in bark and leaf fractions, extracts suppress inflammation-associated molecular signaling, supporting traditional use for swelling, skin conditions, and rheumatic complaints across Pacific Island communities.
**Antimicrobial and Anti-HIV Activity**
Inophyllum C and calanolides A and B—concentrated in seed resin oil and leaves—demonstrate activity against HIV reverse transcriptase and multiple bacterial strains; geographic chemotype variation means French Polynesian material is richer in tamanolide E1/E2 and calanolide Gut 70, while Fijian material predominates in inophyllum C, conferring regionally distinct antimicrobial spectra.
**Skin Repair via Tamanu Oil**
Cold-pressed seed resin oil (tamanu oil) has a long ethnobotanical record in Fiji, New Caledonia, and French Polynesia for promoting cicatrization (scar healing), treating skin infections, and relieving burns; the oil's neoflavonoid and calophyllolide content is credited with stimulating skin cell regeneration, though controlled clinical trials confirming this mechanism in humans remain absent.
**Neuroprotective and BBB-Penetrant Bioactive Compounds**
In silico ADME analysis of key compounds—including eugenol and caryophyllene oxide—predicts high gastrointestinal absorption, blood-brain barrier permeability, and Lipinski compliance, suggesting theoretical neuroprotective potential and good oral bioavailability for further pharmacological investigation.
Origin & History
Natural habitat
Calophyllum inophyllum is a large tropical evergreen tree native to coastal regions of the Indo-Pacific, ranging from East Africa and the Indian subcontinent through Southeast Asia to the Pacific Islands, including Micronesia, Fiji, French Polynesia, and New Caledonia. It thrives in sandy, well-drained coastal soils and is frequently found in littoral forests near beaches and lagoons, tolerating high salinity and periodic flooding. In the Federated States of Micronesia, it is known locally as 'Woleai-gugu' on the Woleai atoll and has been cultivated and harvested for generations as part of indigenous botanical medicine traditions.
“Calophyllum inophyllum occupies a prominent place in the ethnobotanical traditions of Pacific Island societies spanning thousands of years; in Micronesia, specifically on the Woleai atoll of the Federated States of Micronesia, the plant is called 'gugu' and its leaf juice is a recognized remedy for open wound care and the prevention or management of tetanus, a use documented in FSM ethnobotanical surveys. In Polynesia and Melanesia—including Fiji, French Polynesia, and New Caledonia—the seed oil (tamanu oil) is a cornerstone of indigenous healing practice, applied to burns, skin ulcers, leprosy-related lesions, rheumatism, and postpartum recovery, with the oil's preparation by sun-drying seeds followed by cold-pressing representing a technology passed through generations of Pacific healers. The tree holds spiritual and practical significance as a shade and windbreak tree in coastal village landscapes, and its resin oil was historically traded between island groups as a valued medicinal commodity, reflecting its cross-cultural recognition across the Indo-Pacific. Historical European botanical accounts from the 18th and 19th centuries, including observations by naturalists accompanying Pacific voyages, documented indigenous use of tamanu oil, contributing to its eventual adoption in French colonial pharmacy and its later resurgence as a cosmeceutical ingredient in the 20th century.”Traditional Medicine
Scientific Research
The current body of evidence for Calophyllum inophyllum consists entirely of in vitro cell culture experiments and in silico computational analyses, with no published human clinical trials reporting sample sizes, effect sizes, or controlled outcomes as of the available literature. In vitro studies demonstrate antiproliferative activity against patient-derived breast and lung cancer cell lines at 72 hours of exposure, with selective cytotoxicity compared to normal cells, and antibacterial performance measured by MIC (<0.098 mg/mL against Bacillus cereus) and agar diffusion (17.96 mm zone against Staphylococcus aureus). Phytochemical optimization studies have quantified extraction-condition-dependent yields—up to 289.12 mg GAE/g total phenolics and 410.4 mg QE/g total flavonoids under 80% methanol at 30°C for 48 hours—providing reproducible benchmarks for standardization but not translating to human dose-response relationships. The evidence base, while mechanistically plausible and internally consistent across multiple research groups examining different geographic chemotypes, must be characterized as preliminary and preclinical; large-animal toxicology studies and Phase I human trials are required before any therapeutic claims can be substantiated.
Preparation & Dosage
Traditional preparation
**Tamanu Oil (Cold-Pressed Seed Resin)**
Applied topically to wounds, skin infections, and scars; no standardized dose established; traditional application involves direct skin contact with undiluted or carrier-blended oil, typically 2–5 drops per application site.
**Leaf Juice (Fresh Leaf Expression)**
Traditional Micronesian (FSM/Woleai) preparation involves crushing fresh leaves and applying expressed juice directly to wounds or affected skin; frequency and volume are empirical and unstandardized.
**Methanolic Leaf Extract (Research Grade)**
10 mg/mL in in vitro studies; no human equivalent dose established
Optimized at 80% methanol, 30°C, 48 hours extraction; used at .
**Methanolic Bark Extract**
004 mg/mL); no human dose defined
Prepared by solvent maceration; high phenolic/flavonoid yield correlates with antioxidant potency (DPPH IC₅₀ 0..
**Hexane Bark Extract**
Rich in saponins; used as a research fraction for antimicrobial assays; not formulated for human supplementation.
**Standardization Note**
No commercial standardization to specific neoflavonoid (e.g., calophyllolide, inophyllum B/C) content percentages has been formally established; geographic chemotype variation significantly affects compound profiles and should be considered in any future standardization effort.
**Timing and Route**
All traditional use is topical; oral administration has not been assessed in clinical settings and cannot be recommended based on current evidence.
Nutritional Profile
Calophyllum inophyllum is not consumed as a dietary food source and does not contribute macronutrient or conventional micronutrient value to human nutrition; its pharmacological interest lies entirely in its secondary metabolite phytochemical composition. Leaf fractions (methanol-soluble) contain alkaloids (~11.51%), tannins (~7.68%), polyphenols (~2.53%), and triterpenoids (~2.48%) by gravimetric fraction analysis. Leaf extracts optimized under 80% methanol conditions yield total phenolic content (TPC) of up to 289.12 mg gallic acid equivalents (GAE)/g dried residue and total flavonoid content (TFC) of up to 410.4 mg quercetin equivalents (QE)/g, both among the higher values reported for tropical medicinal plants. Seed resin oil contains concentrated neoflavonoids—inophyllums A, B, C, D, E, P; calophyllolide; calanolides A, B, D, Gut 70; and tamanolides D and P—at levels that vary significantly by geographic origin (e.g., higher tamanolide E1/E2 in French Polynesia; higher inophyllum C in Fiji). In silico ADME modeling for representative compounds (eugenol, caryophyllene oxide) predicts high gastrointestinal absorption and favorable Lipinski compliance, but experimental human bioavailability data are absent.
How It Works
Mechanism of Action
Phenolic compounds and flavonoids in Calophyllum inophyllum extracts scavenge reactive oxygen species (ROS) through hydrogen atom transfer and single electron transfer mechanisms, directly neutralizing DPPH and ABTS radicals (DPPH IC₅₀ as low as 0.004 mg/mL for methanolic bark extract), while simultaneously downregulating intracellular ROS-related gene expression pathways implicated in cancer cell proliferation, migration, and invasion. Neoflavonoids—specifically inophyllums B, C, and E—and calanolides A and B inhibit HIV-1 reverse transcriptase through non-nucleoside binding at the reverse transcriptase active site, while inophyllum C additionally targets bacterial membrane integrity and metabolic enzymes in Gram-positive organisms. Calophyllolide exerts anti-inflammatory effects by modulating prostaglandin synthesis pathways and suppressing pro-inflammatory cytokine cascades, an action complemented by alkaloid and tannin fractions (alkaloids 11.51%, tannins 7.68% of methanol-soluble leaf material) that further inhibit microbial enzymatic activity and provide astringent wound-surface protection. Saponins enriched in hexane bark fractions contribute to surfactant-mediated disruption of microbial cell membranes, synergizing with phenolic bacteriostatic action to broaden the antimicrobial spectrum observed in multi-extract MIC assays.
Clinical Evidence
No human clinical trials have been conducted on Woleai-gugu (Calophyllum inophyllum) leaf juice, tamanu oil, or standardized extracts for any indication, including the traditional Micronesian uses of wound healing and tetanus prophylaxis. The entirety of mechanistic evidence derives from in vitro cell-based assays (patient-derived cancer cell lines, bacterial culture MIC/zone-of-inhibition methods) and in silico ADME/drug-likeness computational modeling, neither of which constitutes clinical evidence of efficacy or safety in humans. While the preclinical data are promising—particularly regarding selective anticancer cytotoxicity, potent antioxidant activity, and broad-spectrum antimicrobial action—effect sizes and confidence intervals from human trials are entirely absent, precluding any evidence-based dosing recommendations. Overall confidence in clinical utility is low due to this evidence gap, and the ingredient should be regarded as a candidate for, rather than the subject of, future Phase I/II trial investigation.
Safety & Interactions
Preclinical in vitro data indicate selective cytotoxicity against cancer cell lines with no cytotoxicity to normal cells at 24-hour exposures, suggesting a favorable initial safety window at concentrations studied (around 10 mg/mL in research settings); however, no formal toxicology studies in animals or humans have been published, and maximum safe doses for any route of administration remain undefined. No drug interaction data exist in the human clinical literature; the in silico prediction of minimal CYP450 inhibition for key compounds (eugenol, caryophyllene oxide) is theoretically reassuring but has not been experimentally validated in human hepatic systems, and the presence of multiple bioactive neoflavonoids with unknown CYP450 profiles warrants caution when co-administering anticoagulants, antiretrovirals, or narrow-therapeutic-index drugs. Contraindications are not formally established; topical tamanu oil has anecdotal reports of contact dermatitis in sensitive individuals, and persons with nut or tree resin allergies should exercise particular caution given the seed-oil preparation method. Use during pregnancy and lactation is not supported by any safety data and cannot be recommended; traditional topical use is generally considered low-risk, but ingestion of extracts or oils should be avoided until human safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Calophyllum inophyllumTamanuAlexandrian laurelBallnut treeBeauty leafGugu (Woleai, FSM)Dilo (Fiji)Foraha (Madagascar)
Frequently Asked Questions
What is Woleai-gugu used for in traditional Micronesian medicine?
In the Federated States of Micronesia, particularly on Woleai atoll, fresh leaf juice of Calophyllum inophyllum (locally called gugu) is applied topically to wounds to promote healing and to guard against tetanus infection. This practice leverages the plant's documented antimicrobial phenolics and neoflavonoids, which inhibit pathogens such as Staphylococcus aureus (zone of inhibition 17.96 mm) and Bacillus cereus (MIC <0.098 mg/mL), though no controlled human clinical trials have validated this traditional application.
What are the key bioactive compounds in Calophyllum inophyllum?
The primary bioactive compounds are neoflavonoids—specifically inophyllums A, B, C, D, E, and P; calophyllolide; calanolides A, B, D, and Gut 70; and tamanolides D and P—concentrated in the seed resin oil. Leaf and bark fractions also contain substantial phenolics (up to 289.12 mg GAE/g), flavonoids (up to 410.4 mg QE/g), alkaloids (~11.51%), and tannins (~7.68%), with compound profiles varying significantly by geographic origin and extraction solvent.
Is tamanu oil the same as Woleai-gugu extract?
Tamanu oil and Woleai-gugu both derive from Calophyllum inophyllum, but they represent different preparations from different plant parts. Tamanu oil is cold-pressed from dried seeds and is rich in neoflavonoids and calophyllolide used across Polynesia and Melanesia, while Woleai-gugu preparation in Micronesian FSM tradition specifically uses freshly expressed leaf juice applied topically; both share antimicrobial and anti-inflammatory phytochemicals but differ in compound concentration and traditional cultural context.
Are there any human clinical trials on Calophyllum inophyllum?
No human clinical trials with reported sample sizes, randomization, or quantified effect sizes have been published for Calophyllum inophyllum in any indication. All current mechanistic evidence is derived from in vitro cell culture studies—including patient-derived breast and lung cancer cell lines—and in silico ADME computational modeling; these findings, while scientifically promising, cannot be extrapolated to confirm efficacy or safety in humans without controlled clinical investigation.
What is the recommended dose of Woleai-gugu or tamanu oil?
No standardized supplemental or therapeutic dose has been established for any preparation of Calophyllum inophyllum in humans. Research studies have used concentrations of approximately 10 mg/mL in in vitro assays, which do not translate to human dosing equivalents. Topical tamanu oil is traditionally applied in small amounts (2–5 drops) directly to affected skin, and leaf juice is applied empirically without quantified volume; oral use cannot be recommended due to the absence of human safety and pharmacokinetic data.
Does Woleai-gugu or tamanu oil interact with antibiotics or topical wound treatments?
While Woleai-gugu extract demonstrates antimicrobial activity against pathogens like Staphylococcus aureus and Bacillus cereus, concurrent use with prescription antibiotics should be discussed with a healthcare provider to avoid redundant treatment or potential interactions. Topical application alongside conventional wound care products (such as iodine-based antiseptics or antibiotic ointments) may be safe, but medical guidance is recommended to ensure compatibility and optimal healing outcomes.
Is tamanu oil from Calophyllum inophyllum safe to apply on open wounds, or should it only be used on closed skin?
In traditional Micronesian medicine, the leaf juice of Woleai-gugu has been directly applied to open wounds due to its antimicrobial phenolic compounds and neoflavonoids that inhibit bacterial growth. However, modern wound care protocols recommend consulting a healthcare provider before applying any botanical extract to deep or severe wounds, as clinical evidence on optimal application methods and contamination risks remains limited.
How does Calophyllum inophyllum compare to other tropical antimicrobial herbs like neem or tea tree oil for wound healing?
Woleai-gugu demonstrates significant antimicrobial efficacy with zones of inhibition against Staphylococcus aureus (17.96 mm) and low MIC values against Bacillus cereus, placing it among potent topical antimicrobials used in traditional medicine. While neem and tea tree oil have more extensive modern clinical research, Calophyllum inophyllum's phenolic and neoflavonoid profile offers a distinct phytochemical approach; direct comparative trials between these three botanicals are limited and would clarify relative effectiveness for specific wound types.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w woleai-gugu-calophyllum-inophyllum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
